SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MEDX ... anybody following? -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (747)10/8/2003 1:59:38 PM
From: nigel bates  Read Replies (2) | Respond to of 2240
 
I tend to look at mAbs as a quick and dirty way to get something into the clinic. Once a target has been identified it shouldn't be too difficult to raise some mAbs against it.

Surely we now know it isn't quite as easy as that (or there'd be a lot more in the clinic by now) ?
And finding an optimal small molecule candidate is tougher by an order of magnitude.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News